Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05IEN
|
|||
| Former ID |
DIB006755
|
|||
| Drug Name |
Epstein Barr-based gene therapy
|
|||
| Synonyms |
Epstein Barr-based gene therapy (intradermal, cancer); EBV EBNA1/LMP2 gene therapy vaccine (intradermal, cancer), University of Birmingham; Epstein Barr-based gene therapy (intradermal, cancer), University of Birmingham
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
The University of Birmingham
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin Cancer Res. 2014 Oct 1;20(19):5009-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.